HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Liver transplanted patients with preoperative autoimmune hepatitis and immunological disorders are at increased risk for Post-Transplant Lymphoproliferative Disease (PTLD).

AbstractBACKGROUND:
Long term immunosuppression and therapy of acute rejections result in a 20-120-fold increased risk to develop Non Hodgkin lymphoma (NHL). Since immunosuppressive therapy and immunological disorders are major risk factors for the development of NHL in the non-transplant population we aimed to analyze risk factors for PTLD in our cohort of liver transplanted (LT) patients.
METHODS:
We analyzed retrospectively 431 patients liver transplanted between 1998 and 2008.
RESULTS:
PTLD was diagnosed in eleven of 431 patients (2.6%). PTLD, especially late PTLD, was significantly more frequent in patients who received steroids before LT (Kaplan-Meier: p<0.001). Moreover PTLD in immunocompromised patients with preoperative steroid treatment occurred at a significantly younger age (49.5+/-4.7 years) compared to patients without steroids (60.6+/-5.1 years; p=0.006). Multivariate analysis revealed pretransplant steroid treatment and liver transplantation for autoimmune hepatitis as main risk factors for the development of PTLD after liver transplantation (p<0.001).
CONCLUSION:
Liver transplanted patients who received steroids before LT due to immunological disorders and patients with autoimmune hepatitis seem to be at particular high risk to develop PTLD. Prospective cohort studies including immunoepidemiologic investigations of abnormalities of cellular, humoral and innate immunity should be carried out to identify predictive factors and patients at risk.
AuthorsTim Zimmermann, Maria Hoppe-Lotichius, Vuk Tripkovic, Ana P Barreiros, Thomas C Wehler, Anca Zimmermann, Jörn M Schattenberg, Michael Heise, Stefan Biesterfeld, Peter R Galle, Gerd Otto, Marcus Schuchmann
JournalEuropean journal of internal medicine (Eur J Intern Med) Vol. 21 Issue 3 Pg. 208-15 (Jun 2010) ISSN: 1879-0828 [Electronic] Netherlands
PMID20493424 (Publication Type: Journal Article)
CopyrightCopyright 2010 European Federation of Internal Medicine. Published by Elsevier B.V. All rights reserved.
Chemical References
  • Immunosuppressive Agents
  • Steroids
Topics
  • Adolescent
  • Adult
  • Aged
  • Cadaver
  • Child
  • Female
  • Hepatitis, Autoimmune (drug therapy, immunology, mortality)
  • Humans
  • Immunosuppressive Agents (therapeutic use)
  • Kaplan-Meier Estimate
  • Liver Transplantation (mortality, statistics & numerical data)
  • Lymphoma, Non-Hodgkin (immunology, mortality)
  • Male
  • Middle Aged
  • Multivariate Analysis
  • Postoperative Complications (immunology, mortality)
  • Preoperative Care
  • Proportional Hazards Models
  • Retrospective Studies
  • Risk Factors
  • Steroids (therapeutic use)
  • Tissue Donors (statistics & numerical data)
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: